Tempus Wealth Planning, LLC Pds Biotechnology Corp Transaction History
Tempus Wealth Planning, LLC
- $303 Million
- Q1 2025
A detailed history of Tempus Wealth Planning, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Tempus Wealth Planning, LLC holds 18,800 shares of PDSB stock, worth $26,884. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,800
Previous 18,800
-0.0%
Holding current value
$26,884
Previous $30,000
26.67%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
55Shares Held
8.24MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$6.32 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.16 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$696,3620.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$626,1690.0% of portfolio
-
Blair William & CO Chicago, IL257KShares$367,7960.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $40.7M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...